RE:RE:Beautiful cup and handleI would say there is a much higher bull case for TRIP over MMED. MMED market cap and share structure is scary given they may never recognize revenue for years. CMPS is a much better play with FDA fasttrack and a low share count not to mention institutional investors. I've made some money on MMED but only hold it in the ETF.